Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/23308
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | de Wit, Nienke | - |
dc.contributor.author | VANMOL, Jasmine | - |
dc.contributor.author | Kamermans, A. | - |
dc.contributor.author | HENDRIKS, Jerome | - |
dc.contributor.author | de Vries, Elga | - |
dc.date.accessioned | 2017-03-07T07:48:34Z | - |
dc.date.available | 2017-03-07T07:48:34Z | - |
dc.date.issued | 2016 | - |
dc.identifier.citation | Neurobiology of disease, 107, pag. 57-65 | - |
dc.identifier.issn | 0969-9961 | - |
dc.identifier.uri | http://hdl.handle.net/1942/23308 | - |
dc.description.abstract | The blood-brain barrier (BBB) is indispensable for the maintenance of brain homeostasis and proper neuronal functioning. Dysfunction of the BBB significantly contributes to the pathogenesis of neuroinflammatory and neurodegenerative diseases like stroke, multiple sclerosis (MS), and Alzheimer's disease (AD). The neuroinflammatory environment that characterizes these disorders propagates chronic impaired function of the BBB, processes that will be discussed in this review. Limiting dysfunction of the BBB may be an attractive target for treatment of neurological disorders. To date, no current treatments are directly targeting the function of the BBB. In this review, we will specifically discuss the potential protective role of nuclear liver X receptors (LXRs) as a promising therapeutic target to reverse or prevent BBB impairment in neurological diseases. | - |
dc.description.sponsorship | This work was supported by grants from the ZonMw Memorabel program (NMdW; project nr 733050105) and from the Dutch MS Research Foundation (AK; grant MS-09-358d) | - |
dc.language.iso | en | - |
dc.publisher | ACADEMIC PRESS INC ELSEVIER SCIENCE | - |
dc.rights | © 2016 Elsevier Inc. All rights reserved. | - |
dc.subject.other | Liver X receptor | - |
dc.subject.other | Blood-brain barrier | - |
dc.subject.other | Neuroinflammation | - |
dc.subject.other | Neurodegenerative disease | - |
dc.subject.other | Tight junction | - |
dc.title | Inflammation at the blood-brain barrier: The role of liver X receptors | - |
dc.type | Journal Contribution | - |
dc.identifier.epage | 65 | - |
dc.identifier.spage | 57 | - |
dc.identifier.volume | 107 | - |
local.format.pages | 9 | - |
local.bibliographicCitation.jcat | A1 | - |
dc.description.notes | de Wit, NM (reprint author), Vrije Univ Amsterdam Med Ctr, Dept Mol Cell Biol & Immunol, Neurosci Campus Amsterdam, POB 7057, NL-1007 MB Amsterdam, Netherlands. n.dewit1@vumc.nl | - |
local.publisher.place | 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 | - |
local.type.refereed | Refereed | - |
local.type.specified | Review | - |
dc.identifier.doi | 10.1016/j.nbd.2016.09.015 | - |
dc.identifier.isi | 000411169900006 | - |
local.uhasselt.international | yes | - |
item.fulltext | With Fulltext | - |
item.contributor | de Wit, Nienke | - |
item.contributor | VANMOL, Jasmine | - |
item.contributor | Kamermans, A. | - |
item.contributor | HENDRIKS, Jerome | - |
item.contributor | de Vries, Elga | - |
item.fullcitation | de Wit, Nienke; VANMOL, Jasmine; Kamermans, A.; HENDRIKS, Jerome & de Vries, Elga (2016) Inflammation at the blood-brain barrier: The role of liver X receptors. In: Neurobiology of disease, 107, pag. 57-65. | - |
item.accessRights | Open Access | - |
item.validation | ecoom 2018 | - |
crisitem.journal.issn | 0969-9961 | - |
crisitem.journal.eissn | 1095-953X | - |
Appears in Collections: | Research publications |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Inflammation at the blood-brain barrier AV.pdf | Peer-reviewed author version | 893 kB | Adobe PDF | View/Open |
Inflammation at the blood-brain barrier_ The role of liver X receptors _ Elsevier Enhanced Reader.pdf Restricted Access | Published version | 8.46 MB | Adobe PDF | View/Open Request a copy |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.